Local view for "http://purl.org/linkedpolitics/eu/plenary/2005-11-15-Speech-2-180"
| Predicate | Value (sorted: default) |
|---|---|
| rdf:type | |
| dcterms:Date | |
| dcterms:Is Part Of | |
| dcterms:Language | |
| lpv:document identification number |
"en.20051115.25.2-180"2
|
| lpv:hasSubsequent | |
| lpv:speaker | |
| lpv:spokenAs | |
| lpv:translated text |
"Ladies and gentlemen, I would like to pay tribute to the painstaking work undertaken by the rapporteur Mr Sacconi in preparing this report. As a doctor, I am aware of the considerable rise in the incidence of serious diseases recorded over the last decade, much of which is due to the hazardous use of chemicals. Often, however, problems arise from a failure on the part of manufacturers to provide information concerning the effects of chemicals.
It is important to realise that the REACH directive is not only about the conflict between the chemical industry and the environment, but also about the competition between large corporations and small to medium-sized enterprises in the chemical sector. I welcome the fact that the REACH directive will ban some substances and have them replaced by less dangerous substitutes. However, most of the chemical substances mentioned in the report will not be eliminated from the environment. I hope that people will be directly informed, on the basis of tests, of the dangers they pose. Needless to say, I am also thankful for the fact that people will be more careful when handling such substances.
I do, however, have one serious reservation regarding a kind of discrimination against the ten new Member States. These states have been party to the discussions on the REACH directive for only one year, as a result of which their level of readiness is lower than that of the EU-15, which have been discussing the issue for three years. The Slovak Republic supports and recommends the approval of the ‘one substance, one registration’ system because it contributes to reducing overall testing costs and eliminating unnecessary bureaucracy.
Since the objective of REACH is to reduce the risks posed by chemical substances while avoiding price increases in final products brought about by high testing costs, I believe that it would be appropriate also to standardise testing charges, due account being taken of the weaker economies of the new Member States."@en1
|
Named graphs describing this resource:
The resource appears as object in 2 triples